Immediate management of a newly admitted patient with mental illness who is shouting on a medical ward should prioritise safety, assessment, and de-escalation.
Begin by having one trained staff member take the primary role in communicating with the patient, assessing the situation for safety, listening carefully to understand the cause of distress, and negotiating in a calm, non-confrontational way to reduce agitation NICE NG10. Employ verbal and non-verbal de-escalation techniques, including controlling body posture and eye contact to regulate anxiety and frustration expressions NICE NG10. Where possible, provide a quiet or designated area to help reduce emotional arousal and support the patient to calm down NICE NG10.
It is critical to establish a close working relationship with the patient quickly, greeting them respectfully by their preferred name and title and focusing on their emotional needs and preferences to foster trust and promote safety NICE CG136. Encourage them to recognise their own triggers and early warning signs of agitation, and involve them in discussions about how best to manage these situations NICE NG10. Maintain respectful and empathetic communication throughout the interaction NICE NG10.
Physical and chemical restraint or restrictive interventions should only be used if de-escalation and other preventive strategies have failed, and if there is imminent risk of harm to the patient or others, with trained staff present and all safety measures in place, including resuscitation equipment NICE NG10. When pharmacological interventions are considered, such as rapid tranquillisation or p.r.n. medication to manage agitation, these should be tailored individually with clear rationale, involve the patient where possible, and be carefully monitored as part of a multidisciplinary care plan NICE NG10.
During this acute phase, provide clear verbal and written information to the patient and any carers about the ward environment, available treatments, rules, patients' rights, and visiting arrangements to reduce uncertainty and anxiety NICE CG136,NICE CG155. Begin comprehensive assessment for underlying causes of shouting and agitation, including mental health evaluation and potential delirium screening, given that delirium may present with agitation and shouting and requires prompt treatment NICE CKS.
Document all observations and interventions thoroughly, noting behaviours, triggers, and patient responses, to inform ongoing care and reduce the risk of recurrence NICE CG136. Plan multidisciplinary input early, including mental health specialists and nursing staff trained in de-escalation techniques, and continue psychological support post-discharge if relevant NICE CG155. Where available, tailor interventions to the patient’s cognitive and emotional status—for example, modifying care approaches for patients with dementia or cognitive impairment to emphasise environmental adjustments and safeguarding over behavioural compliance NICE CKS,Da and Xu L. 2025.
Broader context: For patients with prolonged hospitalisation or complex presentations, behavioural challenges including shouting may be exacerbated by social isolation and unmet emotional needs, particularly in psychogeriatric patients, whereby individualized plans addressing social and emotional factors alongside medical treatment are advised Da and Xu L. 2025. In such contexts, educating staff about the underlying factors driving challenging behaviours and encouraging empathetic, patient-centred care can improve outcomes and reduce agitation episodes Da and Xu L. 2025.
Key References
- NICE CG155: Psychosis and schizophrenia in children and young people: recognition and management
- NICE NG10: Violence and aggression: short-term management in mental health, health and community settings
- NICE CG136: Service user experience in adult mental health: improving the experience of care for people using adult NHS mental health services
- NICE CKS: Learning disabilities
- NICE CKS: Self-harm
- NICE CKS: Delirium
- NICE CKS: Psychosis and schizophrenia
- SmPC: Promazine Hydrochloride 50mg/5ml Oral Syrup
- SmPC: Promazine Hydrochloride 25mg/5ml Oral Syrup
- (Da and Xu L., 2025): The prevalence and associated factors of inappropriate sexual behaviour in psychogeriatric inpatients in a Chinese psychiatric hospital: A cross-sectional study.
- (Kaggwa et al., 2026): The prevalence of antipsychotic polypharmacy and its associations with violent behaviors among forensic psychiatry patients.
- (Megersa et al., 2026): Breaking barriers: mental health literacy and stigma in Addis Ababa's schools - a qualitative study in Ethiopia.